San Diego, CA
Summary
This clinical-stage precision oncology company is dedicated to erasing cancer by targeting the RAS/MAPK pathway, a common mutation affecting millions globally. Their innovative pipeline includes a range of therapeutic programs designed to comprehensively inhibit this pathway, aiming to transform cancer treatment and improve patient outcomes. The company emphasizes a mission-driven culture that combines serious scientific endeavors with a positive work environment.
Based on content on erasca.com
No similar companies found
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
6.4 years — Since Aug 2018
Web Hosting
Platform
E-Mail Provider
Mimecast
NAICS Code
325414
SIC 4 Digit Code
2836
SIC 2 Digit Code
28
Industry
1. Biotechnology and Pharmaceuticals
2. Biological Product (except Diagnostic) Manufacturing
Vendor
Source
Sendinblue
TXT Record
Adobe identity provider
TXT Record
Apple
TXT Record
DocuSign
TXT Record
Smartsheet
TXT Record
Mimecast
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|